Infants with Trisomy 18 and Complex Congenital Heart Defects Should Not Undergo Open Heart Surgery

Area of Science:

• Neonatal Medicine
• Genetics
• Medical Ethics

Background:

• Trisomy 18 (Edwards syndrome) is a severe genetic disorder.
• Neonatal outcomes for trisomy 18 are often poor, prompting debate on intervention efficacy.

Purpose of the Study:

• To evaluate the impact of aggressive medical and surgical interventions on survival and quality of life in neonates with trisomy 18.
• To assess the associated morbidity, resource allocation, and costs of these interventions.

Main Methods:

• Review of existing literature and clinical data on trisomy 18 interventions.
• Analysis of survival rates, quality of life indicators, and complication data.
• Examination of healthcare resource utilization and economic costs.

Main Results:

• Evidence demonstrating improved survival with aggressive interventions is lacking.
• No data supports enhanced quality of life for trisomy 18 neonates undergoing aggressive treatment.
• Significant morbidity, substantial resource allocation, and high costs are consistently associated with these interventions.

Conclusions:

• Aggressive medical and surgical interventions offer no proven survival benefit for neonates with trisomy 18.
• Current interventions do not enhance the quality of life for these infants and incur significant burdens.
• Careful consideration of ethical, economic, and clinical factors is crucial when managing trisomy 18 cases.